BModesto ’s Post

Empowering India's Pharmaceutical Landscape: A certificate of completion from Pharmastate Academy after participating in a thought-provoking Panel Discussion on "generic vs branded drugs -What is right for India?" we explored what's best for India's diverse healthcare needs And it is also about finding balance approach between generic and branded drugs that addresses acceptability,effectiveness,trust in medication. Grateful for the insights gained and the opportunity to contribute to shaping the future of our nation's pharmaceutical sector. #Pharmaceuticals #HealthcareDebate #India #PanelDiscussion #PharmastateAcademy

This insightful article challenges the common justification for high US drug prices—that they fund R&D. 💊 It reveals that the premium charged in the US far exceeds what companies spend on global research. 📊 This discrepancy underscores the need for pricing reforms in the pharmaceutical industry. 🌍 A must-read for anyone interested in healthcare policy and drug pricing! 🏥 #Pharmaceuticals #HealthcarePolicy #DrugPricing #Innovation #R&D https://lnkd.in/eeSFrM7a

In the fast-paced medical sector, staying dynamic is key. As Key Account Manager, I took immense pride in not just promoting our top pharmaceutical products, but also identifying those needing a greater focus and promotion. 💊 Every product has potential, they just need the right market-centric strategies. This way, we managed to create core competencies for our top 7 brands. Pharmaceutical professionals, how do you identify potential in your products and ensure they get the attention they deserve? #Pharmaceuticals #MarketStrategy #BusinessDevelopment

In an era where pharmaceutical safety and regulatory compliance are critical, Syngene International Limited stands out as a leader in comprehensive nitrosamine testing. Syngene not only provides cutting-edge analytical services but also offers a holistic approach, integrating risk assessment, impurity profiling, and regulatory support. With its end-to-end capabilities, Syngene helps pharmaceutical companies navigate the complexities of nitrosamine contamination while upholding the highest standards of patient safety. As the industry faces ongoing challenges with nitrosamine impurities, Syngene’s agile solutions deliver excellence and reliability in the global pharmaceutical landscape. Find out more - https://lnkd.in/eBdRfRry #PharmaceuticalSafety #NitrosamineTesting #SyngeneInternational #RegulatoryCompliance #PatientSafety

Our extensive supply of biosimilars places Niromed at the forefront of pharmaceutical distribution, ensuring healthcare providers and patients have access to essential, cost-effective treatments. 🔍 What Are Biosimilars? Biosimilars are akin to generic drugs but for biological medicines. They are officially approved versions of original "innovator" products and are manufactured when the original product's patent expires. Despite minor differences in clinically inactive components, biosimilars match their reference products in terms of safety, efficacy, and quality. 🌟 Most importantly, biosimilars are cost-effective, ensure broader access to medication and encourages pharmaceutical innovation by fostering competition. If you're a healthcare professional seeking reliable biosimilar sources - our expertise and extensive portfolio in biosimilars makes us your trusted ally. #Niromed #biosimilars #pharmaceutical

Top 10 Indian Pharmaceutical Companies India's pharmaceutical industry is one of the largest in the world, playing a crucial role in global healthcare by providing affordable and high-quality medicines. The sector has witnessed significant growth, driven by the increasing demand for generic drugs, innovation in drug development, and a robust manufacturing infrastructure. Here is an in-depth look at the top 10 Indian pharmaceutical companies that are leading the industry. Market Capitalization is in Crore Reference :- Screener, moneycontrol.com, GlobalData Plc #TopPharmaCompanies #IndianPharma #SunPharma #DivisLab #Cipla #ZydusLifesciences #DrReddysLabs #TorrentPharma #MankindPharma #Lupin #AurobindoPharma #AlkemLabs #PharmaceuticalIndustry #Healthcare #ResearchBaba #GlobalPharma #PharmaInnovation #AffordableHealthcare #PharmaLeadership #PharmaR&D #PharmaGrowth

Geographical expertise is essential for successful clinical trials. Logistics companies like COREX provide the necessary knowledge to navigate regulatory and logistical challenges, ensuring efficient delivery and management of medical supplies. Discover the impact of geographical expertise on patient care 👇 #ClinicalTrials #MedicalLogistics

Statistics show that a 20% improvement in logistics efficiency can lead to a 15% reduction in healthcare costs. This is why our role at COREX is so vital – we ensure that medicines and clinical trial supplies reach their destinations swiftly and securely. Discover more about how we contribute to patient care and clinical trials in our latest blog post. It's worth the read!

💊Little is known about how much drug companies earn in sales revenues for new medicines and how long it takes them to recover the costs of research and development. 🆕 Latest publication by Olivier Wouters and co-authors analysed data from company reports to track worldwide sales of new medicines approved by the US Food and Drug Administration (#FDA) from 1995 to 2014. 📑The result shows that companies generated large revenues on sales of new drugs approved from 1995 to 2014, though sales were highly skewed. A majority of products had net discounted sales that exceeded the industry-wide average costs of development within 10 years of approval.  💡 An understanding of the revenues earned by pharmaceutical companies on brand-name drugs, alongside data on business costs, can inform discussions about how to incentivize private investment in innovation while ensuring affordable prices for patients and the health-care system. 🔗Read the full paper👉 https://bit.ly/3XYg3TE #Pharmaceuticals #DrugApproval #FDAApproval #DrugDevelopment

Have you ever wondered why life-saving medications are out of reach for so many people? The pursuit of a high-risk, high-capital endeavor like drug manufacturing can compel pharmaceuticals to price their drugs expensively. The entry of generic drugs into the market provides competing products that are generally priced much lower than the original branded product. Amidst this, The debate between the efficacy and quality of branded v/s generic drugs has been as old as time. However, it is important to note that generic drugs and name drugs use the same active pharmaceutical ingredients (APIs) which speaks to the comparable quality of the two. In recent years, 80 - 90 percent of all prescriptions in the United States have been filled with generic products. We must ensure that essential medications are accessible to everyone, prioritizing patient well-being without compromising on quality. At Gyma, we are constantly striving to make affordable healthcare a reality for all. #pharmaceuticals #drugaffordability #drugdevelopment